B3GAT1 and systemic lupus erythematosus: have shown that the frequency of CD4+CD57+ senescent T cells is notably elevated and is positively correlated with disease activity, indicating that CD4+CD57+ senescent CD4+ T cells play a dominant role in the pathogenesis of SLE and hold promise for developing a potential treatment for ameliorating lupus phenotypes (127).